Fed. Circ. Nixes Inventor's Anti-Coagulant Patent App

Law360, New York (April 19, 2012, 6:57 PM EDT) -- The Federal Circuit rejected a challenge Thursday to a U.S. Patent and Trademark Office decision that sustained the invalidity of an application for a patent covering segments of the heparin molecule designed to stymie blood vessel growth in tumors.

A three-judge panel shot down inventor Shaker A. Mousa's challenge to a Board of Patent Appeals and Interferences ruling that said the heparin fractions disclosed in the application were the same or substantially the same as the heparin fractions taught by a patent issued in 1988....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.